Charles River Laboratories International Inc.
CRL | NYSE
$279.01
+$0.95 (+0.34%)
At close: Sep 21, 2026, 4:00 PM ET
$279.01
$0 (0.00%)
After-hours:
Sep 21, 2026, 5:55 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 26, 2026 | Q1 2026 Mar 27, 2026 | Q4 2025 Dec 26, 2025 | Q3 2025 Sep 26, 2025 | Q2 2025 Jun 27, 2025 | Q1 2025 Mar 28, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 27, 2024 | Q2 2024 Jun 28, 2024 | Q1 2024 Mar 29, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 23, 2022 | Q2 2022 Jun 24, 2022 | Q1 2022 Mar 25, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 24, 2021 | Q2 2021 Jun 25, 2021 | Q1 2021 Mar 26, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1B | 995.83M | 994.23M | 1B | 1.03B | 984.17M | 1B | 1.01B | 1.03B | 1.01B | 1.01B | 1.03B | 1.06B | 1.03B | 1.1B | 989.16M | 973.13M | 913.93M | 905.05M | 895.94M | 914.61M | 824.57M |
Cost of Revenue | 640.7M | 716.51M | 686.37M | 666.06M | 675.07M | 666.44M | 718.31M | 660.74M | 672.4M | 666.72M | 649.39M | 664.78M | 660.96M | 651.72M | 700.96M | 618.93M | 616.41M | 577.11M | 557.94M | 558.71M | 572.59M | 516.29M |
Gross Profit | 363.37M | 279.32M | 307.86M | 338.79M | 357.07M | 317.73M | 284.24M | 349.02M | 353.71M | 344.84M | 364.09M | 361.84M | 398.98M | 377.65M | 398.88M | 370.22M | 356.73M | 336.82M | 347.11M | 337.23M | 342.02M | 308.28M |
Operating Income | 119.89M | 119.9M | 120.22M | 133.8M | 100.13M | 74.67M | -167.69M | 117.41M | 151.65M | 125.98M | 132.92M | 151.5M | 164.95M | 167.89M | 163.81M | 150.98M | 187.41M | 148.78M | 172.81M | 155.8M | 137.55M | 123.7M |
Interest Income | 1.03M | 1.03M | 1.02M | 1.42M | 1.1M | 1.4M | 1.84M | 1.53M | 3.01M | 2.2M | 1.59M | 1.37M | 1.43M | 806K | 343K | 122K | 188K | 127K | 309K | 137K | 171K | 35K |
Pretax Income | 53.17M | -29.94M | -294.1M | 87.2M | 71.42M | 35.98M | -216.79M | 91.24M | 119.65M | 99.01M | 208.71M | 112.87M | 128.66M | 131.04M | 244.92M | 123.11M | 144.11M | 110.85M | 163.64M | 123.27M | 127.5M | 66.3M |
Net Income | -1.48M | -14.84M | -276.56M | 54.42M | 52.33M | 25.47M | -215.7M | 68.68M | 89.99M | 67.33M | 187.08M | 87.39M | 97.02M | 103.13M | 187.41M | 96.47M | 109.32M | 93.02M | 137.58M | 103.43M | 88.45M | 61.53M |
Selling & General & Admin | 228.9M | 159.42M | 187.64M | 177.59M | 191.55M | 177.8M | 195.71M | 199.21M | 169.79M | 186.29M | 197.14M | 176.11M | 199.76M | 174.85M | 199.64M | 183.71M | 131.71M | 150.03M | 144.11M | 148.57M | 171.5M | 155.73M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 14.59M | n/a | n/a | 27.4M | 65.38M | 65.26M | 256.22M | 32.4M | 32.27M | 32.58M | 34.02M | 34.23M | 34.27M | 34.92M | 35.43M | 35.53M | 37.6M | 38.01M | 30.19M | 32.85M | 32.97M | 28.84M |
Operating Expenses | 243.49M | 159.42M | 187.64M | 204.99M | 256.93M | 243.06M | 451.93M | 231.62M | 202.06M | 218.87M | 231.16M | 210.34M | 234.03M | 209.76M | 235.07M | 219.25M | 169.32M | 188.04M | 174.31M | 181.43M | 204.47M | 184.58M |
Interest Expense | 30.34M | 26.74M | 23.78M | 25.4M | 29.97M | 27.88M | 28.23M | 30.28M | 32.77M | 35M | 33.54M | 33.74M | 35.04M | 34.38M | 34.78M | 11.38M | 3.7M | 9.43M | 11.55M | 16.46M | 16.19M | 29.72M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 884.19M | 875.93M | 874.01M | 871.05M | 932M | 909.5M | 1.17B | 892.36M | 874.47M | 885.58M | 880.55M | 875.12M | 894.99M | 861.48M | 936.03M | 838.18M | 785.72M | 765.15M | 732.24M | 740.14M | 777.06M | 700.86M |
Income Tax Expense | 53.93M | -15.14M | -17.81M | 31.64M | 18.73M | 10.1M | -3.04M | 20.95M | 25.39M | 24.53M | 19.75M | 24.85M | 29.22M | 27.09M | 55.82M | 25.5M | 33.45M | 15.62M | 23.82M | 18.11M | 37.58M | 2.37M |
Shares Outstanding (Basic) | 48.49M | 48.95M | 49.22M | 49.21M | 49.15M | 50.68M | 51.14M | 51.39M | 51.55M | 51.44M | 51.31M | 51.28M | 51.22M | 51.31M | 50.91M | 50.87M | 50.82M | 50.64M | 50.47M | 50.43M | 50.3M | 49.98M |
Shares Outstanding (Diluted) | 48.49M | 48.95M | 49.22M | 49.43M | 49.32M | 50.85M | 51.14M | 51.58M | 51.85M | 51.84M | 51.62M | 51.61M | 51.47M | 51.43M | 51.38M | 51.28M | 51.28M | 51.33M | 51.56M | 51.56M | 51.33M | 51.08M |
EPS (Basic) | -0.03 | -0.30 | -5.62 | 1.11 | 1.06 | 0.50 | -4.22 | 1.34 | 1.75 | 1.31 | 3.65 | 1.70 | 1.89 | 2.01 | 3.68 | 1.90 | 2.15 | 1.84 | 2.73 | 2.05 | 1.76 | 1.23 |
EPS (Diluted) | -0.03 | -0.30 | -5.62 | 1.10 | 1.06 | 0.50 | -4.22 | 1.33 | 1.74 | 1.30 | 3.62 | 1.69 | 1.89 | 2.01 | 3.65 | 1.88 | 2.13 | 1.81 | 2.67 | 2.01 | 1.72 | 1.20 |
EBITDA | 150.8M | 63.95M | -192.05M | 197.77M | 220.89M | 184.23M | -86.45M | 209.72M | 238.5M | 219.37M | 322.76M | 225.49M | 241.38M | 242.49M | 357.25M | 209.09M | 224.24M | 195.58M | 242.43M | 208.41M | 211.79M | 157.53M |
EBIT | 83.51M | -3.2M | -270.32M | 112.6M | 101.39M | 63.86M | -188.56M | 121.53M | 152.42M | 134.01M | 242.25M | 146.62M | 163.71M | 165.42M | 279.7M | 134.48M | 147.82M | 120.28M | 175.19M | 139.73M | 143.69M | 96.02M |
Depreciation & Amortization | 67.29M | 67.15M | 78.28M | 85.16M | 119.51M | 120.36M | 102.1M | 88.2M | 86.08M | 85.36M | 80.51M | 78.87M | 77.67M | 77.07M | 77.55M | 74.61M | 76.42M | 75.3M | 67.24M | 68.69M | 68.11M | 61.51M |
Add to Watchlist
Select watchlists to add or remove CRL